PT2572725E - Péptidos frameshift específicos de ims para a prevenção e tratamento do cancro¿ - Google Patents

Péptidos frameshift específicos de ims para a prevenção e tratamento do cancro¿ Download PDF

Info

Publication number
PT2572725E
PT2572725E PT110076841T PT11007684T PT2572725E PT 2572725 E PT2572725 E PT 2572725E PT 110076841 T PT110076841 T PT 110076841T PT 11007684 T PT11007684 T PT 11007684T PT 2572725 E PT2572725 E PT 2572725E
Authority
PT
Portugal
Prior art keywords
fsp
msi
cancer
prevention
treatment
Prior art date
Application number
PT110076841T
Other languages
English (en)
Inventor
Matthias Kloo
Miriam Reuschenbach
Magnus Knebel-Doeberitz
Original Assignee
Ruprecht Karls Universität Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruprecht Karls Universität Heidelberg filed Critical Ruprecht Karls Universität Heidelberg
Publication of PT2572725E publication Critical patent/PT2572725E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/82Colon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/828Stomach
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/836Intestine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/892Reproductive system [uterus, ovaries, cervix, testes]
PT110076841T 2011-09-21 2011-09-21 Péptidos frameshift específicos de ims para a prevenção e tratamento do cancro¿ PT2572725E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007684.1A EP2572725B1 (en) 2011-09-21 2011-09-21 MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer

Publications (1)

Publication Number Publication Date
PT2572725E true PT2572725E (pt) 2015-10-20

Family

ID=44719080

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110076841T PT2572725E (pt) 2011-09-21 2011-09-21 Péptidos frameshift específicos de ims para a prevenção e tratamento do cancro¿

Country Status (5)

Country Link
EP (1) EP2572725B1 (pt)
CY (1) CY1116653T1 (pt)
DK (1) DK2572725T3 (pt)
ES (1) ES2548391T3 (pt)
PT (1) PT2572725E (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101810840B1 (ko) * 2012-12-13 2017-12-20 루프레히트-칼스-유니페어지테트 하이델베르크 암의 예방 및 치료용 msi-특이적 프레임쉬프트 펩티드(fsp)
EP3075389A1 (en) 2015-03-31 2016-10-05 Technische Universität München T cell receptors and peptides derived by mutations for the treatment of cancer
CN110996970A (zh) 2017-06-02 2020-04-10 亚利桑那州立大学董事会 创建个性化癌症疫苗的方法
US20230203130A1 (en) 2020-05-28 2023-06-29 Hubro Therapeutics As A peptide cocktail

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0772619B2 (en) 1994-07-15 2010-12-08 The University of Iowa Research Foundation Immunomodulatory oligonucleotides
AU2003232485A1 (en) * 2002-04-18 2003-10-27 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer

Also Published As

Publication number Publication date
CY1116653T1 (el) 2017-03-15
EP2572725A1 (en) 2013-03-27
EP2572725B1 (en) 2015-07-08
DK2572725T3 (en) 2015-09-21
ES2548391T3 (es) 2015-10-16

Similar Documents

Publication Publication Date Title
EP2832366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER OF BILARY VESICLE
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
EP2740796A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
PT2740794T (pt) Composição farmacêutica para o tratamento e/ou profilaxia de cancro
HUE045461T2 (hu) Gyógyászati készítmény rák kezelésére
PT2818481T (pt) Composição farmacêutica para tratamento e/ou prevenção de cancro
EP2890815A4 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CANCER
EP2688594A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2550263A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
HK1203161A1 (en) Peptides and methods of using same
EP2709614A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF CANCER
HUE038787T2 (hu) Tripeptid készítmények és alkalmazásuk diabétesz kezelésére
HK1201730A1 (en) Treatment agent and or prophylactic agent for side effects of cancer drugs
PT2572725E (pt) Péptidos frameshift específicos de ims para a prevenção e tratamento do cancro¿
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
LT2692662T (lt) Kapsulė ir įrenginys, skirtas šiai kapsulei apdoroti
SG11201502584XA (en) Peptides and methods for treating cancer
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
GB201412831D0 (en) Detection and treatment of breast cancer
HK1205253A1 (en) Detection and treatment of cd30 cancers cd30
EP2957569A4 (en) PEPTIDE (ARG0) N-ANGIOTENSIN- (1-7) AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
IL221238A0 (en) Pharmaceutical compositions and methods for the treatment and prevention of cancer
SG10201601715YA (en) Novel Pharmaceutical Combinations And Methods For Treating Cancer
ZA201107399B (en) Method and compositions for treatment of cancer